ProUroCare Medical Revenue per Share
Revenue per Share of ProUroCare Medical (PUMD) as of Oct 29, 2026.
Get this data via API
Financial Data API
Revenue per Share
0.00USD
Last updated:
Revenue per Share of ProUroCare Medical is 2012 0.00 USD. Revenue per Share of ProUroCare Medical was 2011 - USD. It decreases by % lower compared to the previous year.
The ProUroCare Medical Revenue per Share history
3 Years
10 Years
25 Years
Max
Revenue per Share
Date
Revenue per Share
Jan 1, 2006
0.00 USD
Jan 1, 2007
0.00 USD
Jan 1, 2008
0.00 USD
Jan 1, 2009
0.00 USD
Jan 1, 2010
0.00 USD
Jan 1, 2011
0.00 USD
Jan 1, 2012
0.00 USD
| YEAR | Revenue per Share | YoY |
|---|---|---|
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
ProUroCare Medical Stock analysis
What does ProUroCare Medical do? ProUroCare Medical Inc develops the ProUroScan System, a prostate mechanical imaging device for detecting and characterizing male prostate disease. The system uses sensors on a rectal probe, a central processing unit, and software to generate real-time color images of prostate abnormalities detected via digital rectal examination. It provides elasticity imaging, offering non-invasive tissue analysis, and delivers two- and three-dimensional prostate images. The company sells this medical device directly to healthcare providers for diagnostic use.
The ProUroScan System is marketed as an adjunctive aid for visualizing prostate abnormalities identified during digital rectal exams. Healthcare providers, including urologists and specialists in prostate health, purchase the device to enhance diagnostic capabilities. The product targets medical facilities requiring advanced imaging solutions for prostate disease detection and characterization.
ProUroCare focuses exclusively on the ProUroScan System, with no other products mentioned in the business description. The company’s revenue comes solely from the sale of this imaging system to healthcare professionals and institutions. The device is positioned as a tool for improving diagnostic accuracy in prostate examinations. ProUroCare Medical is one of the most popular companies on Eulerpool.
Frequently Asked Questions about ProUroCare Medical stock
On Eulerpool you can find the complete historical development of Revenue per Share ProUroCare Medical since 2006 – with annual values, charts, and detailed analysis.
Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — ProUroCare Medical
All Key Metrics — ProUroCare Medical
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth